Viewing nowCombinationGablimet Tablets
Vildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Sinphong Pharmaceutical Co., Ltd.

MFDS item code 202107111 · Approved 2021.10.25 · Insurance code 648507960
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication helps patients with type 2 diabetes control their blood sugar levels more effectively when combined with dietary management and exercise. Vildagliptin and Metformin work together to help improve blood glucose levels. Taking this medication can increase the therapeutic effect for those struggling with blood sugar control. Therefore, it is appropriately used for type 2 diabetes that is difficult to manage with limited diet and exercise alone.
For the treatment of patients with type 2 diabetes mellitus, the dose of this medicine should be individualized based on efficacy and tolerability, without exceeding 100mg of vildagliptin and 2000mg of metformin. Doses of 100mg or more of vildagliptin per day are not recommended. This medicine should generally be taken with food or immediately after a meal to reduce gastrointestinal adverse reactions caused by metformin. 1. Patients who have not previously received antidiabetic drug therapy and for whom adequate glycemic control cannot be achieved with monotherapy: The initial dose of this medicine is 1 tablet of 50/500mg once daily. The dose may be gradually increased to 1 tablet of 50/1000mg twice daily. 2. Patients switching from combination therapy with vildagliptin and metformin: Patients switching from combination therapy with vildagliptin and metformin to this medicine may start at their previous doses of vildagliptin and metformin. No studies have been conducted to evaluate the safety and efficacy of switching from another oral antihyperglycemic agent to this medicine. Any change in the treatment regimen for type 2 diabetes mellitus may affect glycemic control; therefore, caution should be exercised and appropriate monitoring should be performed. If you miss a dose of this medicine, take it with your next meal unless it is time to take the next dose. Do not take a double dose at one time to make up for the missed dose. Patients with hepatic impairment This medicine is not recommended for patients with clinical or laboratory evidence of hepatic impairment, including patients whose ALT or AST levels exceed 2.5 times the upper limit of normal before starting treatment with this medicine.
This medication can cause severe lactic acidosis or hypoglycemia, and caution is required. It should not be used in patients with moderate to severe impairment of kidney function or in patients with cardiovascular diseases such as congestive heart failure or acute myocardial infarction. If undergoing examinations using iodine-based contrast agents, this medication should be discontinued 48 hours prior to the examination and can be resumed only after confirming normal kidney function. It should not be administered to individuals with hypersensitivity to this medication or in patients with type 1 diabetes or diabetic ketoacidosis. Patients with severe infections, severe trauma, or scheduled surgery should temporarily stop this medication and resume only after their condition improves and kidney function is confirmed to be normal. Patients with poor nutritional status or impaired liver function and those who consume excessive alcohol should avoid this medication. Women who are pregnant or breastfeeding should not use this medication. Irregular meals, excessive exercise, and combination with certain medications may increase the risk of hypoglycemia and lactic acidosis, so caution is needed. This medication contains the dye Yellow No. 5, so patients allergic to this substance should use it carefully. During treatment, side effects such as headache, dizziness, nausea, and hypoglycemia may occur, and if symptoms such as abnormal liver function, skin rash, or joint pain develop, you should consult a doctor immediately. Particularly, if acute pancreatitis symptoms occur, treatment should be stopped immediately. This medication is not suitable for patients with type 1 diabetes requiring insulin therapy. Regular monitoring of blood sugar, as well as kidney and liver function tests, is necessary, and vitamin B12 levels should also be checked periodically. In cases of overdose, supportive treatment and possibly dialysis may be required. There may be symptoms like dizziness when driving or operating machinery, so caution is advised, and alcohol consumption should be avoided. This medication is not recommended for children and adolescents under 18 years of age. Elderly patients are at risk of reduced kidney function, so dose adjustments and regular kidney function testing are necessary. If any unusual symptoms occur while taking this medication, consult a healthcare professional immediately.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. By storing it this way, the efficacy and safety of the medication can be maintained for a longer period.
Bright yellow oval film-coated tablet
PTP - 30 tablets/box [10 tablets/PTP X3], PTP - 60 tablets/box [10 tablets/PTP X6]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationVildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Sinphong Pharmaceutical Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Korea United Pharm, Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Ahn-Guk Pharmaceutical Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
AhnGuk NewPharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.